For example, 18.2% (2 out of 11) of females with pathogenic MSH6 variants had endometrial cancer, while 36% of those with pathogenic MLH1 variants had a personal history of CRC, and 23% had a family history of CRC. Here, MLH1 is linked to endometrial cancer.